Capoten
Drug - Capoten
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Captopril
Multiple ingredients are in alphabetical order.
Strength -
150MG
The potency of the active ingredient(s), Captopril. May repeat for multiple part products.
Applicant -
PAR PHARM
The firm name holding legal responsibility for Capoten. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
018343
The FDA assigned number to Capoten. Format is nnnnnn.
Product Number -
004
The FDA assigned number to identify Capoten. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jun 13, 1995
The date Capoten was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Capoten. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Capoten is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Par Pharmaceutical Inc
The full name of the firm holding legal responsibility for the new application of Capoten.
Capoten
|
